§ Mr. Carter-Jonesasked the Secretary of State for Social Services (1) if, during the period in which Depo Provera was licensed for use in maintaining pregnancy, any adverse reactions were reported by general practitioners or hospital doctors to the Committee on Safety of Medicines following the use of the drug in such circumstances; and if he will make a statement;
(2) if he will produce a table showing the reports of suspected adverse reactions in Depo Provera detailing the main types of reaction and be date of reports since the drug was first licensed for use in Great Britain in 1968.
§ Dr. VaughanI refer the hon. Member to my reply to him on 7 May.—[Vol. 984, c.160–62.] Since March 1980, the Committee on Safety of Medicines has received three further reports of suspected adverse reactions associated with treatment with Depo Provera: two of these were vascular disorders and one concerned the central nervous system: none followed treatment of habitual or threatened abortion.